M42, Zayed Authority for People of Determination and NMC Healthcare signed a Memorandum of Understanding to explore genetic testing and research for children supported by Mowj Early Intervention Centre. The collaboration aims to improve understanding of neurodevelopmental disorders and developmental delays and inform more personalised clinical care and early intervention.
Under the MoU, M42 will conduct genetic testing and contribute to research, including sample collection, laboratory analysis and sharing results with partners under agreed governance and privacy frameworks. M42 will also participate in research into genetic factors associated with neurodevelopmental conditions.
NMC Healthcare will manage informed consent, genetic counselling and communication of results, and support clinical care planning with specialist teams. Zayed Authority for People of Determination will provide strategic oversight, beneficiary support and coordination with relevant authorities to ensure the initiative meets families’ needs and applicable regulatory requirements.